VITRUVIAN BIO, LLC

ELLICOTT CITY, MD · Medtech · Private

Serological and nucleic acid diagnostic assays that differentiate HIV infection from vaccine-induced seropositivity

Grants
$300K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
$900K
3 awards · Health and Human S
#330 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · SBIR Phase I$300,000
Federal contractDepartment of Health and Human Services · An Electrochemical Self-monitoring Device For Rapid Nucleic Acid Based Testing Of HIV-1$299,968
Federal contractDepartment of Health and Human Services · Nimh SBIR Phase 1 Topic 001- Point-of-care Hiv Viral Load And Drug Adherence Assays$299,999
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
327Neuroptics, Inc.$945K$2.3M
328ACCEL DIAGNOSTICS, LLC$937K—
329AUTONOMOUS HEALTHCARE INC.$925K—
330VITRUVIAN BIO, LLC$900K—
331COVARIS, INC.$900K—
332Kelyniam Global, Inc.$894K$250K
333MAGARRAY, INC.$894K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.